Suchergebnisse - "drug development"

PubPharm (9.303)

101

Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer

enthalten in: Cell insight | 2024

von Wang, W. | Shan, D. | Wang, G. | +4

102

Analysis of the first ten years of FDA's rare pediatric disease priority review voucher program : designations, diseases, and drug development

enthalten in: Orphanet journal of rare diseases | 2024

von Mease, C. | Miller, K. | Fermaglich, L. | +3

ErratumIn: Orphanet J Rare Dis. 2024 Mar 21;19(1):131. - PMID 38515155

103

Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development

enthalten in: Orphanet journal of rare diseases | 2024

von Mease, C. | Miller, K. | Fermaglich, L. | +3

104

Polygonum ciliinerve (Nakai) Ohwi : a review of its botany, traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2024

von Qu, Q. | Zhang, Y. | Zhao, X. | +5

105

Novel and experimental therapeutics for the management of motor and non-motor Parkinsonian symptoms

enthalten in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2024

von Ullah, I. | Wang, X. | Li, H.

106

The status of drug evaluation in older adults in the United Kingdom : Bridging the representation gap

enthalten in: Journal of the American Geriatrics Society | 2024

von Walker, L. | Pirmohamed, M.

107

Drug Mechanism : A bioinformatic update

enthalten in: Biochemical pharmacology | 2024

von Cirinciani, M. | Da Pozzo, E. | Trincavelli, M. | +2

108

The patient perspective on dose optimization for anticancer treatments : A new era of cancer drug dosing-Challenging the "more is better" dogma

enthalten in: Clinical trials (London, England) | 2024

von Maués, J. | Loeser, A. | Cowden, J. | +3

109

New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold

enthalten in: ACS chemical neuroscience | 2024

von Dallanoce, C. | Richter, K. | Stokes, C. | +6

110

Assessing trends in cytokine-CYP drug interaction and relevance to drug dosing

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2024

von Sawant-Basak, A. | Olabode, D. | Dai, D. | +2